| scholarly article | Q13442814 |
| P2093 | author name string | Joseph M Pilewski | |
| Tetsuya Nishimoto | |||
| YunYun Su | |||
| Stanley Hoffman | |||
| Carol Feghali-Bostwick | |||
| Xinh-Xinh Nguyen | |||
| P2860 | cites work | TGF-beta signal transduction | Q22003891 |
| MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling | Q24310282 | ||
| Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells | Q26751234 | ||
| Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
| Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis | Q28534937 | ||
| Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosis | Q28540781 | ||
| TGF-beta signaling and the fibrotic response | Q29620099 | ||
| Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1 | Q73728656 | ||
| A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions | Q77342918 | ||
| The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis | Q77446721 | ||
| The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo | Q87622084 | ||
| Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease | Q30442380 | ||
| Apoptosis and angiogenesis: an evolving mechanism for fibrosis | Q33713723 | ||
| Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis | Q33942836 | ||
| TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). | Q34120419 | ||
| Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease | Q34154288 | ||
| Structure-function analysis of the human insulin-like growth factor binding protein-4. | Q34751766 | ||
| The myofibroblast in pulmonary fibrosis | Q35022198 | ||
| Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition | Q35083605 | ||
| Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. | Q35116144 | ||
| Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide | Q35163605 | ||
| Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration | Q35607286 | ||
| IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF. | Q35672107 | ||
| Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing | Q35765155 | ||
| Changes in causes of death in systemic sclerosis, 1972-2002 | Q35954516 | ||
| Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice | Q35964652 | ||
| Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis | Q36013707 | ||
| Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice | Q36083172 | ||
| The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond | Q36493978 | ||
| IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity | Q36801110 | ||
| Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis | Q36849123 | ||
| Human skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteins | Q36961582 | ||
| Molecular targets in pulmonary fibrosis: the myofibroblast in focus. | Q36969931 | ||
| CCN2, the connective tissue growth factor | Q37031962 | ||
| Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis | Q37115997 | ||
| A peptide derived from endostatin ameliorates organ fibrosis. | Q37340061 | ||
| Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice | Q37452281 | ||
| The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms | Q39821402 | ||
| Transforming growth factor-{beta}-inducible phosphorylation of Smad3 | Q39883712 | ||
| IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis | Q39975112 | ||
| Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells | Q40296058 | ||
| A novel approach to reducing postoperative intraperitoneal adhesions through the inhibition of insulinlike growth factor I activity | Q40719095 | ||
| Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts | Q41700398 | ||
| The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration | Q42066582 | ||
| Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice | Q44018101 | ||
| Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). | Q46896586 | ||
| Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia | Q48471761 | ||
| The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. | Q53966284 | ||
| Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. | Q54446707 | ||
| Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis | Q64377525 | ||
| IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis | Q73160807 | ||
| P433 | issue | 3 | |
| P921 | main subject | connective tissue | Q25615 |
| P304 | page(s) | 167-179 | |
| P577 | publication date | 2018-11-14 | |
| P1476 | title | Insulin-like growth factor binding protein-4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C-X-C chemokine receptor 4 | |
| P478 | volume | 1 |
| Q90639907 | Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis | cites work | P2860 |
Search more.